tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP

Neuphoria Therapeutics (NEUP) Revenue

Compare
247 Followers

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had a revenue of 15.00M in the quarter ending Mar 31, 2025, with 2163.42%. This bring the company's revenue in the last twelve months to 15.66M, Decreased 2263.42%. In the fiscal year ending Jun 30, 2024, Neuphoria Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
15.66M
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
8
Market Cap
$13.54M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
0.00-181.36K-100.00%
Jun 30, 2022
181.36K+∞%
Jun 30, 2021
0.00-32.06K-100.00%
Jun 30, 2020
32.06K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis